At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NVOX Defiance Daily Target 2X Long NVO ETF
Trading 02-06 11:23:56 EST
17.01
+2.31
+15.71%
High17.02Low16.36Vol635.69K
Open16.45D1 Closing14.70Amplitude4.49%
Mkt Cap49.30MTradable Cap47.60MTotal Shares2.90M
T/O10.63MT/O Rate22.72%Tradable Shares2.80M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Hims & Hers Shares Tumble 6.5% in Early Trading Following Legal Threats from Novo Nordisk
Deep News  ·  42 minutes ago
Hims & Hers Shares Tumble 6.5% in Early Trading Following Legal Threats from Novo Nordisk
These Stocks Are Today's Movers: Amazon, Strategy, Novo Nordisk, Molina, Stellantis, Impinj, Doximity, and More -- Barrons.com
Dow Jones  ·  02-06 22:59
These Stocks Are Today's Movers: Amazon, Strategy, Novo Nordisk, Molina, Stellantis, Impinj, Doximity, and More -- Barrons.com
Update: US FDA Warns of 'Swift Action' Against Copycat Drugs
MT Newswires Live  ·  02-06 22:54
Update: US FDA Warns of 'Swift Action' Against Copycat Drugs
Top Premarket Decliners
MT Newswires Live  ·  02-06 21:19
Top Premarket Decliners
Global Equities Roundup: Market Talk
Dow Jones  ·  02-06 20:17
Global Equities Roundup: Market Talk
Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. -- Barrons.com
Dow Jones  ·  02-06 20:04
Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. -- Barrons.com
FDA Vows Crackdown on Unapproved Weight-Loss Drug Copies, Boosting Shares of Novo Nordisk and Eli Lilly
Stock News  ·  02-06 18:44
FDA Vows Crackdown on Unapproved Weight-Loss Drug Copies, Boosting Shares of Novo Nordisk and Eli Lilly
Goldman Sachs: Market Overpricing Novo Nordisk's Pricing Pressure, Oral Wegovy Key to Restoring Confidence
Deep News  ·  02-06 16:28
Goldman Sachs: Market Overpricing Novo Nordisk's Pricing Pressure, Oral Wegovy Key to Restoring Confidence
Novo Nordisk Earnings Call: Growth Engine Meets 2026 Reset
TIPRANKS  ·  02-06 08:21
Novo Nordisk Earnings Call: Growth Engine Meets 2026 Reset
Novo Nordisk Warns of Legal Action Against Hims & Hers Over Compounded Weight-Loss Drug
Deep News  ·  02-06 05:04
Novo Nordisk Warns of Legal Action Against Hims & Hers Over Compounded Weight-Loss Drug
Novo Nordisk Publishes 2025 Annual Report
TIPRANKS  ·  02-06 04:18
Novo Nordisk Publishes 2025 Annual Report
Novo Nordisk Launches DKK 3.8 Billion Share Buyback as Part of 2026 Repurchase Plan
TIPRANKS  ·  02-06 04:18
Novo Nordisk Launches DKK 3.8 Billion Share Buyback as Part of 2026 Repurchase Plan
Novo Nordisk Discloses Management Share Transfers Under Long-Term Incentive Plan
TIPRANKS  ·  02-06 04:17
Novo Nordisk Discloses Management Share Transfers Under Long-Term Incentive Plan
European Equities Decline as Novo Nordisk Slumps
Deep News  ·  02-06 02:31
European Equities Decline as Novo Nordisk Slumps
Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
Benzinga_recent_news  ·  02-06 01:51
Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
Novo Nordisk Accuses Hims & Hers of 'Illegal Mass Compounding' Over Hims & Hers's Cheaper Wegovy Version -- 2nd Update
Dow Jones  ·  02-06 01:47
Novo Nordisk Accuses Hims & Hers of 'Illegal Mass Compounding' Over Hims & Hers's Cheaper Wegovy Version -- 2nd Update
Top Midday Stories: Alphabet Shares Fall Despite Q4 EPS, Revenue Beats; Rio Tinto Ends Merger Talks With Glencore
MT Newswires Live  ·  02-06 00:42
Top Midday Stories: Alphabet Shares Fall Despite Q4 EPS, Revenue Beats; Rio Tinto Ends Merger Talks With Glencore
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
MT Newswires Live  ·  02-06 00:14
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
Novo Nordisk issues statement on ‘inauthentic’ Hims & Hers semaglutide pill
TIPRANKS  ·  02-05 23:50
Novo Nordisk issues statement on ‘inauthentic’ Hims & Hers semaglutide pill
Hims & Hers to Offer Copy of Novo's Wegovy Pill for $49 per Month, Reuters Reports
MT Newswires Live  ·  02-05 21:57
Hims & Hers to Offer Copy of Novo's Wegovy Pill for $49 per Month, Reuters Reports

Introduction

Company Name.
Defiance Daily Target 2X Long NVO ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
Issue price:
--